Latest Insider Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL)
This section provides a real-time view of insider transactions for Zentalis Pharmaceuticals, Inc. (ZNTL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Zentalis Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Zentalis Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 05
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
28,204
-1.26%
|
$1,240,976
$44.01 P/Share
|
|
Apr 05
2021
|
David Michael Johnson Director |
SELL
Open market or private sale
|
Direct |
12,897
-12.67%
|
$554,571
$43.5 P/Share
|
|
Apr 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,210
-2.43%
|
$181,030
$43.96 P/Share
|
|
Mar 10
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,720
-7.41%
|
$212,400
$45.24 P/Share
|
|
Mar 03
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
3,700
-5.49%
|
$166,500
$45.07 P/Share
|
|
Mar 01
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-1.08%
|
$126,403
$41.67 P/Share
|
|
Mar 01
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.74%
|
$410,000
$41.69 P/Share
|
|
Mar 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.75%
|
$1,098,554
$41.53 P/Share
|
|
Mar 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,210
-5.88%
|
$172,610
$41.65 P/Share
|
|
Feb 11
2021
|
Cam Gallagher President, Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
13,750
+1.19%
|
-
|
|
Feb 11
2021
|
Dimitris Voliotis SVP, Clinical Development |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+50.0%
|
-
|
|
Feb 11
2021
|
Anthony Y Sun President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+2.38%
|
-
|
|
Feb 11
2021
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+1.76%
|
-
|
|
Feb 11
2021
|
Alexis Pinto Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+50.0%
|
-
|
|
Feb 11
2021
|
Epperly Melissa B, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+4.97%
|
-
|
|
Feb 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,210
-2.82%
|
$155,770
$37.56 P/Share
|
|
Feb 01
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.88%
|
$370,000
$37.71 P/Share
|
|
Feb 01
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.56%
|
$114,071
$37.89 P/Share
|
|
Feb 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.5%
|
$991,378
$37.82 P/Share
|
|
Jan 04
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.28%
|
$157,233
$51.97 P/Share
|
|
Jan 04
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-2.59%
|
$429,420
$51.95 P/Share
|
|
Jan 04
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
26,567
-0.64%
|
$1,354,917
$51.81 P/Share
|
|
Jan 04
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.43%
|
$510,000
$51.88 P/Share
|
|
Jan 04
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.37%
|
$1,366,494
$51.85 P/Share
|
|
Dec 24
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
1,600
-0.15%
|
-
|
|
Dec 24
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Indirect |
18,473
-56.17%
|
-
|
|
Dec 08
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
22,573
-0.76%
|
$1,264,088
$56.22 P/Share
|
|
Dec 07
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
35,606
-0.44%
|
$1,851,512
$52.87 P/Share
|
|
Dec 07
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,892
-0.26%
|
$566,384
$52.87 P/Share
|
|
Dec 07
2020
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,464
-0.57%
|
$336,128
$52.87 P/Share
|
|
Dec 07
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
6,692
-0.28%
|
$347,984
$52.87 P/Share
|
|
Dec 04
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
39,769
-0.95%
|
$1,988,450
$50.96 P/Share
|
|
Dec 04
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,165
-0.57%
|
$608,250
$50.96 P/Share
|
|
Dec 04
2020
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,220
-1.25%
|
$361,000
$50.96 P/Share
|
|
Dec 04
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
7,474
-0.61%
|
$373,700
$50.96 P/Share
|
|
Dec 02
2020
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.26%
|
$157,233
$51.78 P/Share
|
|
Dec 02
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.32%
|
$1,366,494
$51.27 P/Share
|
|
Dec 02
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.4%
|
$510,000
$51.26 P/Share
|
|
Dec 02
2020
|
David Michael Johnson Director |
SELL
Open market or private sale
|
Direct |
12,896
-2.93%
|
$657,696
$51.24 P/Share
|
|
Dec 01
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-1.88%
|
$437,840
$52.41 P/Share
|
|
Dec 01
2020
|
Viking Global Investors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
500,000
-11.25%
|
$25,000,000
$50.5 P/Share
|
|
Nov 24
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
11,386
-0.18%
|
$523,756
$46.82 P/Share
|
|
Nov 23
2020
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.79%
|
$460,000
$46.87 P/Share
|
|
Nov 23
2020
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
15,408
-0.36%
|
$708,768
$46.82 P/Share
|
|
Nov 23
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,425
-2.85%
|
$387,550
$46.85 P/Share
|
|
Nov 23
2020
|
Kevin D. Bunker Chief Scientific Officer |
BUY
Bona fide gift
|
Indirect |
101,045
+50.0%
|
-
|
|
Nov 23
2020
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
101,045
-8.58%
|
-
|
|
Nov 23
2020
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.52%
|
$141,818
$46.88 P/Share
|
|
Nov 22
2020
|
Anthony Y Sun President & CEO |
BUY
Bona fide gift
|
Indirect |
213,600
+50.0%
|
-
|
|
Nov 22
2020
|
Anthony Y Sun President & CEO |
SELL
Bona fide gift
|
Direct |
213,600
-10.59%
|
-
|